Peer Review Papers in Journals
Shorvon SD, Reynolds EH
Unnecessary polypharmacy in the treatment of epilepsy
British Medical Journal 1977; i: 1635-1637
Shorvon SD, Chadwick D, Galbraith A, Reynolds EH
One drug for epilepsy
British Medical Journal 1978; i: 474-476
Shorvon SD, Reynolds EH
Reduction of polypharmacy for epilepsy
British Medical Journal 1979; i: 1023-1025
Shorvon SD
Epilepsy and suicide
British Medical Journal 1980; 281: 530
Shorvon SD, Carney M, Chanarin I, Reynolds EH
The neuropsychiatry of megaloblastic anaemia
British Medical Journal 1980; 281: 1036-1038
Reynolds EH, Shorvon SD, Galbraith AW, Chadwick D, Dellaportas CI, Vyedelingam L
Phenytoin monotherapy for epilepsy: A long term prospective study, assisted by serum level monitoring in previously untreated patients
Epilepsia 1981; 22: 475-488
Reynolds EH, Shorvon SD
Monotherapy or polytherapy for epilepsy
Epilepsia 1981; 22: 1-10
Reynolds EH, Shorvon SD
Single drug or combination therapy for epilepsy
Drugs 1981; 21: 374-382
Shorvon SD, Reynolds EH
Early prognosis of epilepsy
British Medical Journal 1982; 285: 1699-1701
Shorvon SD, Reynolds EH
Anticonvulsant peripheral neuropathy: A clinical and electrophysiological study
Journal of Neurology, Neurosurgery Psychiatry 1982; 45: 620-626 (and 1983; 46:; matters arising)
Gedroyc W, Shorvon SD
Acute intracranial hypertension and nalidixic acid therapy
Neurology 1982; 32: 212-215
Dellaportas CI, Shorvon SD, Galbraith AW, Laundy M, Chanarin I, Marshall W, Reynolds EH
Chronic toxicity in epileptic patients
British Medical Journal 1982; 285: 409-410
Shorvon SD
Specialised services for the non-institutionalised patient with epilepsy: developments in the US and UK
Health Trends 1983; 15: 40-45
Goodridge DMG, Shorvon SD
Epilepsy in a population of 6000: 1. demography, diagnosis and classification, and the role of the hospital services
British Medical Journal 1983; 287: 641-644
Goodridge DMG, Shorvon SD
Epilepsy in a population of 6000: 2. Treatment and prognosis
British Medical Journal 1983; 287: 645-648
Reynolds EH, Elwes RDC, Shorvon SD
Why does epilepsy become intractable?
Lancet 1983; ii: 952-954
Shorvon SD
The temporal aspects of prognosis in epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1984; 47:1157-1165
Shorvon SD, Gilliatt RW, Cox TCS, Yu YL
Evidence of vascular disease from CT scanning in late onset epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1984; 47: 225-230
Elwes RDC, Johnson AL, Shorvon SD, Reynolds EH
Remission and relapse rates in newly diagnosed epileptic patients
New England Journal of Medicine 1984; 311:944-947
Pratt J, Jenner P, Shorvon SD, Reynolds EH
Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function
Journal of Neurology, Neurosurgery & Psychiatry 1984;47: 1131-1133
Patsalos P, Shorvon SD, Smith G, Elias A
The interaction of Denzimol (a new anticonvulsant) with phenytoin and carbamazepine
Journal of Neurology Neurosurgery & Psychiatry 1985; 48:374-377
Shorvon SD, Espir MLE, Steiner TJ, Dellaportas CI, Rose FC
In there a place for placebo-controlled trials of antiepileptic drugs?
British Medical Journal 1985; 291: 1328-1329
Shorvon SD
Drugs in developing countries
British Medical Journal 1986; 292: 1666-1667
Shorvon SD
Non convulsive status epilepticus
Lancet 1987; i: 958-959
Espir MLE, McCarthy M, Shorvon SD
Survey of specialised hospital services for adults with epilepsy in the North East Thames Region of the United Kingdom
Neuroepidemiology 1987; 6:94-100
Sander JWAS, Shorvon SD
Incidence and prevalence studies in epilepsy and their methodological problems: a review
Journal of Neurology, Neurosurgery & Psychiatry 1987 50: 829-839
Duncan JS, Shorvon SD
Rates of antiepileptic drug reduction in active epilepsy – current practice
Epilepsy Research 1987; 1: 357-364
Oxley J, Espir M, Shorvon S, Goodridge D, Richens A
The framework of medical care for epilepsy
Health Trends 1987; 4:13-17
Betts T, Chadwick D, Espir M, Parsonage M, Reynolds E, Shorvon S, Wallace S
Another opportunity to improve epilepsy services should not be lost
Journal of the Royal Society of Medicine 1987; 604-605
Sander JWAS, Shorvon SD
Epilepsy in the community
Journal of the Royal College of General Practitioners 1988; 51-52
Roberts RC, Shorvon SD, Cox TCS, Gilliatt RW
Clinically unsuspected cerebral infarction revealed by computer tomography scanning in late onset epilepsy
Epilepsia 1988; 29: 190-194
Shorvon SD, Farmer PJ
Epilepsy in developing countries: a review of epidemiological, socio-cultural and treatment aspects
Epilepsia 1988; 29: 36-54
Duncan JS, Shorvon SD, Trimble MR
Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate
Journal of Neurology, Neurosurgery & Psychiatry 1988; 51: 924-928
Patsalos PN, Duncan JS, Shorvon SD
The effect of the removal of individual antiepileptic drugs on antipyrine kinetics in patients taking polytherapy
British Journal of Clinical Pharmacology 1988; 26: 253-259
Shorvon SD
Surgery of temporal lobe epilepsy
Lancet 1988; ii: 1115-1116
Shorvon SD
Pseudostatus epilepticus
Lancet 1989; 335: 485
Hart YM, Sander JWAS, Shorvon SD
The National General Practice Study of Epilepsy (NGPSE): aims and study methodology of the largest prospective cohort study of epilepsy yet undertaken
Neuroepidemiology 1989; 8: 221-227
Russell Jones D, Shorvon SD
The frequency and sequalae of head injury in epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1989; 52: 659-662
Duncan JS, Smith SJ, Forster A, Shorvon SD, Trimble MR
The effects of the removal of phenytoin, carbamazepine and sodium valproate on the electro-encephalogram
Epilepsia 1989; 30: 590-596
Duncan JS, Shorvon SD, Trimble MR
Effects of removal of phenytoin, carbamazepine and sodium valproate on cognitive
function
Epilepsia 1990 31: 584-591
Duncan JS, Shorvon SD, Trimble MR
Discontinuation of phenytoin, carbamazepine and valproate in patients with active epilepsy
Epilepsia 1990; 31; 324-333
Yepez-Lasso R, Duncan JS, Shorvon SD
Suppression of inter-ictal spikes by CM40907. A double blind placebo-controlled investigation and review of spike counting as a methodology for assessing the antiepileptic effect of drugs
Epilepsy Research 1990; 5: 247-250
Patsalos PN, Russell-Jones D, Finnerty G, Sander JWAS, Shorvon SD
The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy
Epilepsy Research 1990; 5: 235-239
Shorvon SD
Epidemiology, classification, natural history and genetics of epilepsy
Lancet 1990; 336: 93-96
Sander JWAS, Hart YM, Johnson AL, Shorvon SD
The National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population
Lancet 1990; 336: 1267-1271
Hart YM, Sander JWAS, Johnson AL, Shorvon SD
National General Practice Study of Epilepsy: recurrence after a first seizure
Lancet 1990; 336: 1271-1274
Sander JWAS, Trevisol-Bittencourt PC, Hart YM, Shorvon SD
Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1990; 53: 1008-1010
Chaplin J, Yepez R, Shorvon SD, Floyd M
A quantitative approach to measuring the social effects of epilepsy
Neuroepidemiology 1990; 9: 151-158
Meierkord H, Shorvon SD
Epilepsie bie neuroakanthozytose
Nervenarzt 1990; 61: 692-694
Sander JWAS, Trevisol-Bittencourt PC, Hart YM, Patsalos PN, Shorvon SD
The efficacy and long term tolerability of lamotrigine in the treatment of severe epilepsy
Epilepsy Research 1990; 7: 226-229
Shorvon SD
Medical assessment and treatment of chronic epilepsy
British Medical Journal 1991; 302: 363-366
Duncan JS, Patsalos PN, Shorvon SD
Effects of discontinuation of phenytoin, carbamazepine and valproate on concomitant antiepileptic medication
Epilepsia 1991; 32: 101-115
Shorvon SD
The lack of funds for clinical epilepsy research in the UK
Journal of the Royal College of Physicians 1991; 25: 31-32
Feksi AT, Kaamugisha J, Sander JWAS, Gatiti S, Shorvon SD
Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya
Lancet 1991; 337: 406-409
Feksi AT, Kaamugisha J, Gatiti S, Sander JWAS, Shorvon SD
A comprehensive community epilepsy programme: the Nakuru Project
Epilepsy research 1991; 8: 252-259
Hart YM, Meinardi H, Sander JWAS, Nutt D, Shorvon SD
The effects of intravenous flumazenil on inter-ictal spike activity: results of a placebo controlled investigation
Journal of Neurology, Neurosurgery & Psychiatry 1991; 54: 305-309
Sander JWAS, Hart YM, Trimble MR, Shorvon SD
Vigabatrin and psychosis
Journal of Neurology, Neurosurgery & Psychiatry 1991; 54:435-439
Wroe SJ, Pires M, Harding B, Youl BD, Shorvon SD
Whipples disease confined to the CNS, presenting with multiple intracranial mass lesions
Journal of Neurology, Neurosurgery & Psychiatry 1991; 54: 989-992
Meierkord H, Will B, Fish D, Shorvon SD
The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry
Neurology 1991; 41: 1643-1646
Meierkord H, Shorvon SD
Variations on a theme: singing as an epileptic automatism
Journal Neurology, Neurosurgery & Psychiatry 1991; 54: 1114-1116
Meierkord H, Fish DR, Smith SJM, Scott CA, Shorvon SD, Marsden CD
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy?
Movement Disorders 1992; 9: 38-42
Meierkord H, Shorvon S, Lightman S, Trimble M
Comparison of the effects of frontal and temporal lobe partial seizures on prolactin levels
Archives of Neurology 1992; 49: 225-230
Manford M, Shorvon SD
Prolonged sensory or visceral symptoms: an underdiagnosed form of focal (simple partial) status epilepticus
Journal of Neurology, Neurosurgery & Psychiatry 1992; 55:714-716
Chaplin JE, Yepez Lasso R, Shorvon SD, Floyd M
National General Practice Study of Epilepsy: The social and psychological effects of a recent diagnosis of epilepsy
British Medical Journal 1992; 304: 1416-1418
Manford M, Hart YM, Sander JWAS, Shorvon SD
National General Practice Study of Epilepsy (NGPSE): The syndromic classification of the ILAE applied to epilepsy in a general population
Archives of Neurology 1992; 49: 801-809
Manford M, Hart YM, Sander JWAS, Shorvon SD
National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population
Neurology 1992; 34: 1911-1917
Placencia M, Shorvon SD, Paredes V, Bimos C, Sander JWAS, Suarez J, Cascante SM
Epileptic seizures in an Andean region of Ecuador: incidence and prevalence and regional variation
Brain 1992; 115: 771-782
Placencia M, Sander JWAS, Shorvon SD, Ellison RH, Cascante S
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies
Brain 1992; 115: 783-794
Placencia M, Suarez J, Crespo F, Shorvon SD, Sander JWAS, Ellison RH, Cascante S
A large scale study of epilepsy in Ecuador: methodological aspects
Neuroepidemiology 1992; 11: 74-84
Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM
Hippocampal volumetric studies in temporal and frontal lobe epilepsy
Brain 1992; 115: 1001-1015
Farmer PJ, Placencia M, Jumbo L. Sander JWAS, Shorvon SD
Help-seeking strategies for epilepsy by previously untreated patients in Northern Ecuador
Epilepsy Research 1992; 11: 205-213
Kratimenos GP. Pell MF, Thomas DGT, Shorvon SD, Fish DR, Smith SJN
Open stereotactic selective amygdalo-hippocampectomy for drug resistant epilepsy
Acta Neurochirurgica 1992; 116: 150-154
Farmer PJ, Placencia M, Jumbo L, Sander JWAS, Shorvon SD
Effects of epilepsy on daily functioning in northern Ecuador: summary of findings of a population-based research project
Neuroepidemiology 1992; 11: 180-189
Shorvon SD
Tonic clonic Status epilepticus
Journal of Neurology, Neurosurgery & Psychiatry 1993; 56: 125-134
Klenerman P, Sander JWAS, Shorvon SD
Mortality in patients with epilepsy: a study in patients in long term residential care
Journal of Neurology, Neurosurgery & Psychiatry 1993; 56: 149-152
Sander JWAS, Barclay J, Shorvon SD
The medical founders of the National Society for Epilepsy and the Chalfont Centre for Epilepsy
Journal of the Royal Society of Medicine 1993; 56: 599-604
Sharief M, Sander JWAS, Shorvon SD
The effect of oral flumazenil on interictal epileptic activity: results of a double-blind placebo-controlled study
Epilepsy Research 1993; 15: 53-60
Cockerell C, Sander JWAS, Shorvon SD
Neuroepidemiology in the United Kingdom
Journal of Neurology, Neurosurgery & Psychiatry 1993; 56: 735-738
Kratemenos GP, Thomas DGT, Shorvon SD, Fish DR
Stereotactic insertion of intracerebral electrodes in the investigation of epilepsy
British Journal of Neurosurgery 1993; 7: 45-52
Brown S, Betts T, Chadwick D, Hall B, Shorvon S, Wallace S
An epilepsy needs document
Seizure 1993; 2: 91-104
Placencia M, Sander JWAS, Shorvon SD, Roman M, Alarcon F, Bimos C, Cascante S
Antiepileptic drug treatment in a community health-care setting in northern Ecuador: a prospective 12-month assessment
Epilepsy Research 1993; 14: 237-244
Kitchen ND, Thomas DGT, Thompson PJ, Shorvon SD, Fish DR
Open stereotactic amygdalohippocampectomy – clinical, psychometric and MRI follow up
Acta Neurochirurgica 1993; 123: 33-38
Patsalos PN, Wilson SJ, Popovic M, Cowan JMA, Shorvon SD, Hjelm M
The prevalence of valproic-acid-associated hyperammonaemia in patients with intractable epilepsy resident at the Chalfont Centre for Epilepsy
Journal of Epilepsy 1993; 6: 228-232
Kuks JBM, Cook MJ, Fish DR, Stevens JM, Shorvon SD
Hippocampal sclerosis in epilepsy and childhood febrile seizures.
Lancet 1993; 342: 1391-1394
Kratimenos G, Thomas DGT, Shorvon SD, Fish DR
Stereotactic insertion of intracerebral electrodes in the investigation of epilepsy
British Journal of Neurosurgery 1993; 7: 45-52
Kitchen ND, Thomas DGT, Shorvon SD, Fish DR, Stevens JM
Volumetric analysis of epilepsy surgery resections using high resolution magnetic resonance imaging – technical report
British Journal of Neurosurgery 1993; 7: 651-656
Placencia M, Sander JWAS, Roman M, Madera A, Crespo F, Cascante S, Shorvon S
The characteristics of epilepsy in a largely untreated population in rural Ecuador
Journal of Neurology, Neurosurgery & Psychiatry 1994; 57: 320-325
Shorvon SD
The outcome of tonic-clonic status epilepticus: editorial review
Current Opinion in Neurology 1994; 7: 93-95
Cockerell OC, Sander JWAS, Shorvon SD
The cost of epilepsy in the United Kingdom: an estimation based on the results of two population based studies
Epilepsy Research 1994; 18: 249-260
Meierkord H, Shorvon SD, Lightman SL
Plasma concentrations of prolactin, noradrenalin, vasopressin and oxytocin during and after a prolonged epileptic seizure
Acta Neurological Scandinavica 1994; 90: 73-77
Abed WT, Alavijeh MS, Bayston R, Shorvon SD, Patsalos PN
An evaluation of the epileptogenic properties of a rifampicin/clindamycin impregnated shunt catheter
Journal of Neurology, Neurosurgery & Psychiatry 1994; 8: 725-730
Raymond AA, Halpin SFS, Alsanjari N, Cook MJ, Kitchen ND, Fish DR, Stevens JM, Harding BN, Scaravelli F, Kendall B, Shorvon SD, Neville BGR
Dysembryoplastic neuroepithelial tumours: features in 16 patients
Brain 1994; 117: 461-475
Raymond AA, Fish DR, Stevens JM, Sisodya SM, Shorvon SD
Subependymal heterotopia: a distinct neuronal migration disorder associated with epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1994; 57: 1195-1202
Kitchen ND, Thomas DGT, Fish DR, Shorvon SD, Stevens JM
Image-guided audit of surgery for temporal lobe epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1994; 57: 1221-1227
Cockerell OC, Walker CM, Sander JWAS, Shorvon SD
Complex partial status epilepticus: a recurrent problem
Journal of Neurology, Psychiatry & Neurosurgery 1994; 57: 835-837
Cockerell OC, Johnson AL, Sander JWAS, Hart YM, Goodridge DMG, Shorvon SD
Mortality from epilepsy: results from a prospective population-based study
Lancet 1994; 344: 918-921
Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodiya SM, Shorvon SD
Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy
Neurology 1994; 44: 1841-1845
Cook MJ, Free SL, Manford MRA, Fish DR, Shorvon SD, Stevens J
Fractal description of cerebral cortical patterns in frontal lobe epilepsy
European Neurology 1995; 35: 327-335
Quirk JA, Fish DR, Smith SJM, Sander JWAS, Shorvon SD, Allan PJ
First seizures associated with playing electronic screen games: a community based study in Great Britain
Annals of Neurology 1995; 37: 733-737
Placencia MP, Farmer PJ, Jumbo L, Sander JWAS, Shorvon SD
Level of stigmatisation of patients with previously untreated epilepsy in Northern Ecuador
Neuroepidemiology 1995; 14: 147-154
Walker CM, Smith SJM, Shorvon SD
The intensive care treatment of drug resistant convulsive status epilepticus in the UK: a national survey and recommendations
Anaesthesia 1995; 50: 130-135
Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM
Methods for normalisation of hippocampal volumes measured by MR
American Journal of Neuroradiology 1995; 16: 637-643
Cockerell OC, Gupta S, Catchpole M, Sander JWAS, Shorvon SD
The British Neurological Surveillance Unit: a nationwide scheme for the ascertainment of rare neurological disorders
Neuroepidemiology 1995; 14: 182-187
Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD
Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dyembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, electroencephalographic and neuroimaging features in 100 adult patients
Brain 1995; 118: 629-660
Bergin PS, Oatridge A, Fish DR, Shorvon SD, Bydder GM
Magnetic resonance imaging in partial epilepsy: additional abnormalities revealed by using a fluid attenuated inversion recovery sequence (FLAIR)
Journal of Neurology, Neurosurgery & Psychiatry 1995; 58: 439-443
Shorvon SD
Driving licence regulations and epilepsy – the UK regulations were recently changed
British Medical Journal 1995; 310: 885-886
Walker MC, Galley PT, Errington ML. Shorvon SD, Jefferys JGR
Ascorbate and glutamate release in the rat hippocampus following perforant path stimulation – a “dialysis electrode” study
Journal of Neurochemistry 1995; 65: 725-731
Sisodiya SM, Free SL, Fish DR, Shorvon SD
Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy
Brain 1995; 118: 1039-1050
Nashef L, Fish DR, Garner S, Sander JWAS, Shorvon SD
Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty
Epilepsia 1995; 36: 1187-1194
Van Paesschen W, Sisodiya S, Connelly A, Duncan JS, Free SL, Raymond AA, Grunewald RA, Revesz T, Shorvon SD, Fish DR, Stevens JM, Scaravilli F, Harkess WFJ, Jackson GD
Quantitative hippocampal MRI and intractable temporal lobe epilepsy
Neurology 1995; 45: 2233-2240
Bergin PS, Thompson PJ, Fish DR, Shorvon SD
The effect of seizures on memory for recently learned material
Neurology 1995; 45: 236-240
Nashef L, Fish DR, Sander JWAS, Shorvon SD
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre
Journal of Neurology, Neurosurgery & Psychiatry 1995; 58: 462-464
Hart Y, Shorvon SD
The nature of epilepsy in the general population: 1. characteristics of patients receiving medication for epilepsy
Epilepsy Research 1995; 21: 43-49
Hart Y, Shorvon SD
The nature of epilepsy in the general population: 2. Medical care
Epilepsy Research 1995; 21: 51-58
Cockerell OC, Eckle I, Goodridge DM, Sander JWAS, Shorvon SD
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence and prognosis
Journal of Neurology, Neurosurgery & Psychiatry 1995; 58: 570 -576
Quirk JA, Fish DR, Smith SJM, Sander JWAS, Shorvon SD, Allen PJ.
Incidence of photosensitive epilepsy: a prospective national study.
Electroencephalography and Clinical Neurophysiology 1995; 95: 260-267
Tofts PS, Sisodiya SM, Barker GJ, Webb S, McManus D, Fish DR, Shorvon SD
MR magnetisation transfer measurements in temporal lobe epilepsy – a preliminary study
American Journal of Neuroradiology 1995; 16: 1862-1863
Li LM, Fish DR, Sisodiya SM, Shorvon SD, Alsanjari N, Stevens JM
High resolution magnetic resonance imaging scanning in adults with partial or secondarily generalised epilepsy attending a tertiary referral unit
Journal of Neurology, Neurosurgery & Psychiatry 1995; 59: 384-387
Cockerell OC, Johnson AJ, Sander JWAS, Hart YM, Shorvon SD
Remission of epilepsy: results from the National General Practice Study of Epilepsy
Lancet 1995; 346: 140-144
Walker MC. Smith SJM, Sisodiya SM, Shorvon SD
A case of simple partial status epilepticus in occipital lobe epilepsy misdiagnosed as migraine: clinical electrophysiological and MRI characteristics
Epilepsia 1995; 36: 1233-1236
Sisodiya SM, Free SL, Fish DR, Shorvon SD
Increasing the yield from volumetric MRI in patients with epilepsy
Magnetic Resonance Imaging 1995; 13: 1147-1152
Chaplin JE, Shorvon SD, Floyd M, Lasso RY
Psychosocial factors in the chronicity of epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1995; 58: 112-113
Cendes F, Cook MJ, Watson C, Andermann F, Fish DR, Shorvon SD, Bergin P, Free S, Dubeau F, Arnold DL
The frequency and incidence of dual pathology in patients with lesional epilepsy
Neurology 1995; 45: 2058-2064
Kitchen ND, Cook MJ, Shorvon SD, Fish DR, Stevens JM, Thomas DGT
A method to determine the volume of brain resected during lesional epilepsy surgery
American Journal of Neuroradiology 1995; 16: 208-210
Nashef L, Garner S, Fish DR, Sander JWAS, Shorvon SD
Sudden death in an adult out-patient cohort with epilepsy
Neuroepidemiology 1995; 14: 31-32
Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM
Proposed methods for normalisation of hippocampal volumes measured with MR
American Journal of Neuroradiology 1995; 16: 637-643
Free SL, Li LM, Fish DR, Shorvon SD
Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis
Epilepsia 1996; 37: 400-405
Nashef L. Walker F, Allen P, Sander JWAS, Shorvon SD, Fish DR
Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy
Journal of Neurology, Neurosurgery & Psychiatry 1996; 60: 297-300
Sisodiya SM, Stevens JM, Fish DR, Free SL, Shorvon SD
The demonstration of gyral abnormalities in patients with cryptogenic partial epilepsy using three-dimensional MRI
Archives of Neurology 1996; 53: 28-34
Walker MC, Alavijeh MS, Shorvon SD, Patsalos PN
Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal lobe
Epilepsia 1996; 37: 421-427
Manford MR, Fish DR, Shorvon SD
An analysis of clinical seizure patterns and their localising value in frontal and temporal lobe epilepsies
Brain 1996; 119: 17-40
Sisodiya SM, Free SL, Fish DR, Shorvon SD
MRI-based surface area estimates in the normal human brain: evidence for structural organisation
Journal of Anatomy 1996; 188: 425-438
Shorvon SD
Safety of topiramate: adverse events and relationships to dosing
Epilepsia 1996; 37 (suppl 1): S20-S24
Shorvon SD
The epidemiology and treatment of chronic and refractory epilepsy
Epilepsia 1996; 37 (suppl 1): 1-3
Reutens DC, Stevens JM, Kingsley D, Moseley I, Cook MJ, Free S, Fish DR, Shorvon SD
Reliability of visual inspection for detection of volumetric hippocampal asymmetry
Neuroradiology 1996; 38: 221-225
Manford RA, Fish DR, Shorvon SD
Startle provoked epileptic seizures: features in 19 patients
Journal of Neurology, Neurosurgery & Psychiatry 1996; 61: 151-156
Patsalos PN, O’Connell MT, Doheny HC, Sander JWAS, Shorvon SD
Antiepileptic drug pharmacokinetics in patients with epilepsy using a new microdialysis probe: Preliminary observations
Acta Neurochirurgica 1996; 67: 59-62
Cockerell OC, Goodridge DMG, Brodie D, Sander JWAS, Shorvon SD
Neurological disease in a defined population: results of a pilot study in two general practices.
Neuroepidemiology 1996; 15: 73-82
Sharief MK, Singh P, Sander JWAS, Patsalos PN, Shorvon SD
An efficacy and tolerability study of UCB LO59 in patients with refractory epilepsy
Journal of Epilepsy 1996; 9: 106-112
Baxendale SA, Thompson PJ, Savey L, Bhattacharya J, Shorvon SD
Dose effects on intracarotid sodium amytal performance
Journal of Epilepsy 1996; 9: 135-143
Cockerell OC, Gupta S, Sander JWAS, Shorvon SD
Risk factors for cancer and vascular death in patients with epilepsy in a community and a residential population: a case control study
Journal of Epilepsy 1996; 9: 23-26
Wieshmann UC, Free SL, Everitt AD, Bartlett PA, Barker GJ, Tofts P, Duncan JS, Shorvon SD, Stevens JM
Magnetic resonance imaging in epilepsy with a fast FLAIR sequence
Journal of Neurology, Neurosurgery & Psychiatry 1996; 61: 357-361
Tassinari CD, Michelucci R, Chauvel P, Clodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Kaim R
Double-blind, placebo-controlled trial of Topiramate (600mg daily) for the treatment of refractory partial epilepsy.
Epilepsia 1996; 37: 763-768
Free SL, Sisodiya SM, Cook MJ, Fish DR, Shorvon SD
Three-dimensional fractal analysis of white matter surface from magnetic resonance images of the human brain
Cerebral Cortex 1996; 6: 830-836
Nashef L, Fish DR, Sander JWAS, Shorvon SD
Sudden death in epilepsy: an overview
Journal of Neurology, Neurosurgery & Psychiatry 1996; 60: 111-124
Cockerell OC, Rothwell J, Thompson PJ, Shorvon SD
Clinical and physiological features of Epilepsia Partialis Continua: cases ascertained in the UK
Brain 1996; 119: 393-407
Sander JWAS, Shorvon SD
Epidemiology of the epilepsies
Journal of Neurology, Neurosurgery & Psychiatry 1996; 61: 433-443
Walker MC, Howard R, Smith SJ, Miller D, Shorvon SD, Hirsch NP
Diagnosis and treatment of status epilepticus on a neurological intensive care unit
Quarterly Journal of Medicine 1996; 89: 913-920
Cockerell OC, Walker MC, Sander JWAS, Shorvon SD
Complex partial status
Neurology 1996; 47: 307-308
Cockerell OC, Moriaty J, Trimble M, Sander JWAS, Shorvon SD
Acute psychological disorders in patients with epilepsy: a nation-wide study
Epilepsy Research 1996; 23: 119-131
Li LM, Cendes F, Watson C, Andermann F, Fish DR, Free S, Olivier A, Harkness W, Thomas DGT, Duncan JD, Sander JWAS, Shorvon SD, Cook MJ, Dubeau F, Arnold DL
Surgical treatment of patients with single and dual pathology: relevance of the lesion and of hippocampal atrophy to seizure outcome
Neurology 1997 48: 437-444
Cockerell OC, Johnson AL, Sander JWAS, Shorvon SD
Prognosis of epilepsy: further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population based study
Epilepsia 1997; 38: 31-46
Li LM, Fish DR, Raymond AA, Sisodiya SM, Shorvon SD, Stevens JM
-4 Hz generalised spike and wave discharges in adults with cortical dysgenesis
Shorvon SD
Risk factors for sudden unexpected death in epilepsy
Epilepsia 1997 38 (suppl 11): 20-22
Weishmann UC, Symms MR, Shorvon SD
Diffusion changes in status epilepticus
Lancet 1997 350 493-494
Sisodiya SM, Moran N, Free S, Kitchen ND, Stevens JM, Harkness WFJ, Fish DR, Shorvon S
Correlation of widespread preoperative magnetic resonance imaging changes with unsuccessful surgery for hippocampal sclerosis
Annals of Neurology 1997; 43: 490-496
Sisodiya S, Free SL, Stevens JM, Fish DR, Shorvon SD
Widespread cerebral structural changes in two patients with gelastic seizures and hypothalamic hamartomata
Epilepsia 1997 38: 1008-1010
Shorvon S, Stefan H
Overview of the safety of newer antiepileptic drugs
Epilepsia 1997 38: 45-51
Baxendale S, Van Paesschen W, Thompson PJ, Duncan JS, Shorvon SD, Connelly A
The relation between quantitative MRI measures of hippocampal structure and the intracarotid amylobarbital test
Epilepsia 1997 37: 998-1007
Shorvon SD
Antiepileptic drug monotherapy versus polytherapy: economic aspects
Epilepsia 1997 38 (suppl 5): S17-20
Shorvon SD
Drug treatment of epilepsy
The Pharmaceutical Journal 1997 258: 126 (letter)
Sisodya SM, Free SL, Fish DR, Stevens JM, Shorvon SD
Structural heterogeneity in apparently isolated symptomatic subependymal heterotopia
Neurology
Wieshmann UC, Woerman FG, Lemieux L, Free SL, Bartlett PA, Smith SJM, Duncan JR, Stevens JM, Shorvon SD
Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalised status epilepticus
Epilepsia 1997 38: 1238-1241
Nashef L, Shorvon SD
Mortality in epilepsy
Epilepsia 1997 10: 1059-61
Shorvon SD
MRI of Cortical Dysplasia
Epilepsia 1997 38 (suppl 10): 13-18
Maudgil DM, Shorvon SD
Localising the epileptic focus by MRI
Science and Medicine 1997; 4: 26-35
Brodie M, Shorvon SD, Canger R, Halasz P, Johannessen S, Thomson P, Wieser HG, Wolf P
Commission on European Affairs: Appropriate standards of epilepsy care across Europe
Epilepsia 1997 38: 1245-1250
Wallace H, Shorvon SD, Hopkins A
An audit of the organisation of adult epilepsy services within the UK: a comparative review of epilepsy and general neurology clinics
Seizure 1997 6: 185-191
Walker MC, Tong X, Brown S, Shorvon SD, Patsalos PN
Comparison of single- and repeated- dose pharmacokinetics of diazepam
Epilepsia 1998 39: 283-289
Shorvon SD
The use of clobazam, midazolam and nitrazepam in epilepsy
Epilepsia 1998 39 (suppl 1): S15-23
Baxendale SA, van Paesschen W, Thompson PJ, Connelly A, Duncan J, Harkness WF, Shorvon SD
The relationship between quantitative MRI and neuropsychological functioning in temporal lobe epilepsy
Epilepsia 1998 39: 158=166
Wieshmann UC, Free SL, Stevens JM, Shorvon SD
Image contrast and hippocampal volumetric measurements
Magnetic Resonance Imaging 1998 16: 13-17
Nashef L, Garner S, Sander JWAS, Fish DR, Shorvon SD
Circumstances of death in sudden death in epilepsy: interviews with bereaved relatives
Journal of Neurology, Neurosurgery and Psychiatry 1998 63: 349-353
Baxendale SA, Van Paesschen W, Thompson PJ, Duncan JS, Harkness WF, Shorvon SD
Hippocampal cell loss and gliosis: relationship to preoperative and postoperative memory function
Neuropsychiatry, Neuropsychology and Behavioural Neurology 1998 11: 12-21
Heaney DC, Shorvon SD, Sander JWAS
An economic appriasal of carbamazepine, lamotrigine, phnytoin and valproate as initial treatment in adults with newly diagnosed epilepsy
Epilepsia 1998 39 (suppl 3): S19–25
Wallace H, Shorvon SD, Tallis R
Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age specific fertility rates of women with epilepsy
Lancet 1998: 352 1970-1974
Lemieux L. Wieshmann UC, Moran N, Fish DR, Shorvon SD
The detection and significance of subtle changes in mixed signal brain lesions by serial MRI scan matching and spatial normalisation
Medical Image Analysis 1998 2 227-2442
Wieshmann UC, Barker GJ, Symms MR, Bartlett PA, Stevens JM, Shorvon SD
Fast fluid-attenuated inversion-recovery imaging: first experience with a 3D version in epilepsy
Neuroradiology 1998 40: 483-9
Brown S, Betts T, Crawford P, Hall B, Shorvon S, Wallace S
Epilepsy needs revisited: a revised epilepsy needs document
Seizure 1998 7: 435-46
Lhatoo S, Shorvon SD
Relevance of the first seizure
Lancet 1998 352: 1003-4
Sisodiya S, Free S, Shorvon SD
Surgical Treatment of hypothalamic hamartoma
Annals of Neurology 1998 43: 272-5
Heaney DC, Shorvon SD, Sander JWAS
An economic appraisal of carbamazepine, lamotrigine, phnytoin and valproate as initial treatment in adults with newly diagnosed epilepsy
Epilepsia 1998 39 (suppl 3): S19–25
Maudgil DD, Free SL, Sisodiya SM, Lemieux L, Woermann FG, Fish DR, Shorvon SD
Identifying homologous anatomical landmarks on reconstructed magnetic resonance images of the human cerebral cortical surface
Journal of Anatomy 1998; 193: 559-571
Wieshmann UC, Symms MR, Mottershead JP, MacManus DG, Barker GJ, Tofts PS, Revesz T, Stevens JM, Shorvon SD
Hippocampal layers on high resolution magnetic resonances images: real or imaginary
Journal of Anatomy 1999 195 131-135
Li LM, Cendes SF, Andermann F, Watson C, Fish DR, Cook MJ, Dubeau F, Duncan JS, Shorvon SD, Berkovic SF, Free S, Olivier A, Harkness W, Arnold D
Surgical outcome in patients with epilepsy and dual pathology
Brain 1999 22: 799-805
Moran NF, Fish DR, Kitchen N, Shorvon SD, Kendall BE, Stevens JM
Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series
Journal of Neurology Neurosurgury and Psychiatry 1999 66: 561-8
MacDonald BK, Johnson AL, Sander JWAS, Shorvon SD
Febrile convulsions in 220 children — neurological sequalae at 12 years follow up
European Neurology 1999 41: 179-186
Moran NF, Lemieux L, Maudgil D, Kitchen ND, Fish DR, Shorvon SD
Analysis of temporal lobe resections in MR images
Epilepsia 1999 40: 1077-84
Wieshmann UC, Symms MR, Clark CA, Lemieux L, Franconi F, Parker G, Barker GJ, Shorvon SD
Wallerian degeneration in the optic radiation after temporal lobectomy demonstrated in vivo with diffusion tensor imaging
Epilepsia 1999 40: 1155-1158
Wieshmann UC, Clark CA, Symms MR, Barker GJ, Birnie KD, Shorvon SD
Water diffusion in the human hippocampus in epilepsy
Magnetic resonance imaging 1999 17: 29-36
Wieshmann UC, Symms MR, Bartlett P, Shorvon SD, Clark C, Barker GJ
Diffusion weighted MRI demonstrates abnormal pyramidal tract in hemiparesis
Journal of Neurology, Neurosurgery and Psychiatry 1999 66: 797-798
Heaney DC, Sander JWAS, Shorvon SD
The cost of side-effects of antiepileptic drugs
Epilepsia 1999 40: 97
Baxendale SA, Sisodiya SM, Thompson PJ, Free SL, Kitchen ND, Stevens JM, Harkness W, Fish DR, Shorvon SD
Disproportion in the distribution of gray and white matter — neuropsychological correlates
Neurology 1999: 52: 248-252
Scott CA, Fish DR, Smith SJM, Free SL, Stevens JM, Thompson PJ, Duncan JS, Shorvon SD, Harkness W
Presurgical evaluation of patients with epilepsy and a normal MRI: the role of scalp video-EEG telemetry
Journal of Neurology, Neurosurgery and Pscyhiatry 1999 66: 69-71
Sisodiya SM, Free SL, Thom M, Everitt AE, Fish DR, Shorvon SD
Evidence for epileptogenicity and gender differences in periventricular nodular heterotopia
Neurology 1999 52: 336-341
Wieshmann UC, Clark CA, Symms MR, Franconi F, Barker GJ, Shorvon SD
Anisotropy of water diffusion in corona radiata and cerebral peduncle in patients with hemipareisis
NeuroImage 19999 10: 225-230
Walker MC, Perry H, Scaravilli F, Patsalos PN, Shorvon SD, Jefferys JGR
Halothane as a neuroprotectant during constant stimulation of the perforant path
Epilepsia 1999 40: 359-364
Wieshmann UC< Symms MR, Clark CA, Lemieux L, Parker GJ, Barker GJ, Shorvon SD
Blunt-head trauma associated with widespread water-diffusion changes
Lancet 1999 353: 1242-1243
Wieshmann UC, Clark CA, Symms MR, Franconi F, Barker GJ, Shorvon SD
Reduced anisotropy of water diffusion in cerebral abnormalities demonstrated by diffusion tensor imaging
Magnetic Resonance Imaging 1999 17: 1269-1274
MacDonald BK, Sander JWAS, Shorvon SD
The incidence and lifetime prevalence of neurological disorders in a prospective community based study in the United Kingdom
Brain 2000 123: 665-676
Shorvon SD
Oxcarbazepine: a review
Seizure 2000 9: 75-79
Bergin PS, Thompson PJ, Baxendale SA, Fish DR, Shorvon SD
Remote memory in epilepsy
Epilepsia 2000 41: 231-240
Heaney SC, Shorvon SD, Sander JWAS, Boon P, Komarek V, Marusic P, Dravet C, Perruca E, Majkowski J, Lima JL, Arroho S, Tomson T, Reid S, van Donselaar C, Eskazan E, Peeters P, Carita P, Tjong-a-Hung I, Myon E, Taieb C.
Cost minimisation analysis of anti-epileptic drugs in newly diagnosed epielspy in 12 European countries
Epilepsia 2000; 41 (suppl 5): S37-S44
Liu RSN, Lemieux L. Shorvon SD, Sisodiya SM, Duncan JS.
Association between brain size and abstention from alcohol.
Lancet 2000; 355: 1979-1970
MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JWAS, Shorvon SD.
Factors predicting prognosis of epilepsy after presentation with seizures.
Annals of Neurology 2000; 48: 833-841
Moran N, Poole K, Bell GJ, Solomon JK, Kendall S, McCarthy M, McCormick D, Nashef L, Johnson AJ, Sander JW, Shorvon SD
NHS Services for epilepsy from the patient’s perspective: a survey of primary, secondary and tertiary care access throughout the UK
Seizure 2000; 9:559-565
Poole K, Moran N, Bell GJ, Solomon JK, Kendall S, McCarthy M, McCormick D, Nashef L, Johnson AJ, Sander JW, Shorvon SD
Patients’ perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy.
Seizure 2000; 9: 551-558
Wieshmann UC, Symms MR, Parker GJM, Clark CA, Lemieux L, Barker GJ, Shorvon SD.
Diffusion tensor imaging demonstrates deviation of fibres in normal appearing white matter adjacent to a brain tumour
J Neurol, Neurosurg Psychiat 2000; 68: 162-169
Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T
Assessing risk to benefit ratio in antiepileptic therapy
Epilepsy research; 2000 41: 107-130
Arroyo S, Fossas P, Nieto-Barrera M, Salas-Puig X, Sanchez-Alvarez JM, Serratosa L, Soler-Singla L, Heaney DC, Sander JW, Shorvon SD
Analisis de coste-minimizacion del tratamiento antiepileptico en monoterapia en pacientes con epilepsia de reciente diagnostico situacion en Espana
Rev Neurol 2000 31: 828-832
Grant R, Shorvon SD
Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy
Epilepsy research 2000 42: 89-96
Shorvon SD, Lowenthal A, Janz D, Loiseau P (for the European Levetiracetam Study Group).
Multicentre double-blind placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial epilepsy.
Epilepsia 2000; 41: 1179-1186
Perucca E, Beghi E, Dulac O, Shorvon SD, Tomson T
Assessing risk to benefit ratio in antiepileptic drug therapy
Epilepsy Research 2000: 41: 107-139
Grant R, Shorvon SD.
Efficacy and tolerability of 1000mg/day to 4000mg/day of levetiracetam in add-on therapy in patients with refractory epilepsy.
Epilepsy Research 2000; 42: 89-96
Wieshmann UC, Krakow K, Symms MR, Parker GJ, Clark CA, Barker GJ, Shorvon SD.
Combined functional magnetic resonance imaging and diffusion tensor imaging demonstrate widespread modified organisation in malformation of cortical development.
Journal of Neurology Neurosurgery & Psychiatry. 2001; 70:521-3.
Shorvon S.
The management of status epilepticus.
Journal of Neurology Neurosurgery & Psychiatry. 2001;70 Suppl 2:II22-7.
Heaney DC, Sander JW, Shorvon SD.
Comparing the cost of epilepsy across eight European countries.
Epilepsy Research. 2001;43(2):89-95.
Free SL, O’Higgins P, Maudgil DD, Dryden IL, Lemieux L, Fish DR, Shorvon SD
Landmark-based morphometrics of the normal adult brain using MRI.
Neuroimage. 2001 13(5):801-13.
Lhatoo SD, Johnson AL, Goodridge DM, MacDonald BK, Sander JW, Shorvon SD
Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.
Annals of Neurology. 2001;49(3):336-44.
Moran NF, Lemieux L, Kitchen ND, Fish DR, Shorvon SD.
Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis.
Brain. 2001;124:167-75.
Sisodiya SM, Free SL, Williamson KA, Mitchell TN, Willis C, Stevens JM, Kendall BE, Shorvon SD, Hanson IM, Moore AT, van Heyningen V
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans
Nature Genetics. 2001 28(3):214-6.
Liu RS, lemieux L, Be.. GS, Bartlett PA, Sander JW, Sisodiya SM, Shorvon SD, Duncan JS
A longitudinal quantitative MRI study of community-based patients with chronic epilepsy and newly diagnosed seizures: methodology and preliminary findings.
Neuroimage. 2001 l;14):231-43.
Perucca E, Dulac O, Shorvon S, Tomson T
Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation.
CNS Drugs. 2001;15:609-21.
Lhatoo SD, Sander JW, Shorvon SD.
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 years.
J Neurol Neurosurg Psychiatry. 2001;71:632-7.
Shorvon SD
New Drug Classes: Pyrrolidone derivatives
Lancet 2001; 2001: 1885-1892
Van Paesschen W., Sisodiya S., Connelly A., Duncan J. S., Free S. L., Raymond A. A., Grunewald R. A., Revesz T., Shorvon S. D., Fish D. R., Stevens J. M., Johnson C. L., Scaravilli F., Harkness W. F. J., Jackson G. D
Quantitative hippocampal MRI and intractable temporal lobe epilepsy.
Neurology 2001; 57: S5-S12.
Stefan H, Halasz P, Gil-Nagel A, Shorvon S, Bauer G, Ben-Menachem E, Perucca, E, Wieser HG, Steinlein O.
Recent advances in the diagnosis and treatment of epilepsy.
Eur J Neurol. 2001; 8: 519-39
Shorvon SD, Van Rijckevorsal.
A new antiepileptic drug
Journal of Neurology, Neurosurgery and Psychiatry 2002; 72: 2-5
Mitchell TN, Stevens JM, Free SL, Sander JW, Shorvon SD, Sisodiya SM.
Anterior commissure absence without callosal agenesis: a new brain malformation.
Neurology. 2002; 23;58:1297-9.
Shorvon S.
Antiepileptic drug therapy during pregnancy: the neurologist’s perspective.
J Med Genet. 2002; 39:248-50.
Cock HR, Tong X, Hargreaves IP, Heales SJ, Clark JB, Patsalos PN, Thom M, Groves M, Schapira AH, Shorvon SD, Walker MC.
Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat.
Epilepsy Res. 2002; 48:157-68.
Shorvon SD, Tallis RC, Wallace HK.
Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice.
J Neurol Neurosurg Psychiatry. 2002;72:114-5.
Liu RS, Lemieux L, Bell GS, Sisodiya SM, Bartlett PA, Shorvon SD, Sander JW, Duncan JS.
The structural consequences of newly diagnosed seizures.
Ann Neurol. 2002 52:573-80.
Shorvon S.
Does convulsive status epilepticus (SE) result in cerebral damage or affect the course of epilepsy–the epidemiological and clinical evidence?
Prog Brain Res. 2002;135:85-93. .
Hagemann G, Lemieux L, Free SL, Krakow K, Everitt AD, Kendall BE, Stevens JM, Shorvon SD.
Cerebellar volumes in newly diagnosed and chronic epilepsy.
J Neurol. 2002 249:1651-8. Erratum in: J Neurol. 2003 Feb;250(2):251.
Bell GS, Nashef L, Kendall S, Solomon J, Poole K, Johnson AL, Moran NF, McCarthy M, McCormick D, Shorvon SD, Sander JW.
Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study.
Epilepsy Res. 2002 52 :139-46.
Lhatoo SD, Solomon JK, McEvoy AW, Kitchen ND, Shorvon SD, Sander JW.
A prospective study of the requirement for and the provision of epilepsy surgery in the United kingdom.
Epilepsia. 2003 44:673-6.
Mitchell TN, Free SL, Williamson KA, Stevens JM, Churchill AJ, Hanson IM, Shorvon SD, Moore AT, van Heyningen V, Sisodiya SM.
Polymicrogyria and absence of pineal gland due to PAX6 mutation.
Ann Neurol. 2003 May;53: 658-63.
Mitchell TN, Free SL, Merschhemke M, Lemieux L, Sisodiya SM, Shorvon SD.
Reliable callosal measurement: population normative data confirm sex-related differences.
Am J Neuroradiol. 2003 24:410-8.
Liu RS, Lemieux L, Bell GS, Hammers A, Sisodiya SM, Bartlett PA, Shorvon SD, Sander JW, Duncan JS.
Progressive neocortical damage in epilepsy.
Ann Neurol. 2003 53:312-24.
Ramachandran V, Shorvon SD.
Clues to the genetic influences of drug responsiveness in epilepsy.
Epilepsia. 2003 44 Suppl 1:33-7.
Weale M, Depont C, Macdonald S, Smith A, Lee WL, Lai PS, Shorvon S, Wood N, Goldstein D.
Limited haplotype diversity in the neuronal sodium channel gene SCN1A: Implications for haplotype tagging and linkage disequilibrium mapping.
American Journal of Human Genetics. 2003 Jul 29 [Epub ahead of print]
Liu RS, Lemieux L, Bell GS, Sisodiya SM, Shorvon SD, Sander JW, Duncan JS.
A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis.
Neuroimage. 2003 20:22-33.
Weale ME, Depondt C, Macdonald SJ, Smith A, Lai PS, Shorvon SD, Wood NW, Goldstein DB.
Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping.
Am J Hum Genet. 2003 73:551-65. Epub 2003 Jul 29.
Free SL, Mitchell TN, Williamson KA, Churchill AJ, Shorvon SD, Moore AT, van Heyningen V, Sisodiya SM.
Quantitative MR image analysis in subjects with defects in the PAX6 gene.
Neuroimage. 2003 20:2281-90.
Cleary P, Shorvon SD, Tallis R.
Late-onset seizures as a predictor of subsequent stroke.
Lancet. 2004 ;363 : 1184-6.
Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grunewald RA, Kasteleijn-Nolst Trenite DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S.
Efficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters.
Epilepsia. 2004 45:1646-9
Shorvon SD.
Longer term outcome of children born to mothers with epilepsy.
J Neurol Neurosurg Psychiatry 2004 75:1517-8.
Gaitatzis A, Johnson AL, Chadwick DW, Shorvon SD, Sander JW.
Life expectancy in people with newly diagnosed epilepsy.
Brain. 2004 ; 127:2427-32.
Moran NF, Poole K, Bell G, Solomon J, Kendall S, McCarthy M, McCormick D, Nashef L, Sander J, Shorvon SD.
Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy.
Seizure. 2004 ;13:425-33.
Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grunewald RA, Kasteleijn-Nolst Trenite DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S.
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Neurology. 2005 64:172-4
Shorvon SD.
Classification of status epilepticus.
Epileptic Disord. 2005;7:1-3
Tate SK, Depondt C, Sisodiya SM, Cavalleri GL, Schorge S, Soranzo N, Thom M, Sen A, Shorvon SD, Sander JW, Wood NW, Goldstein DB.
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs
carbamazepine and phenytoin.
Proc Natl Acad Sci U S A. 2005;102:5507-12
Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, Aylett S, Besag F, Cock H, Delorenzo R, Drislane F, Duncan J, Ferrie C, Fujikawa D, Gray W, Kaplan P, Koutroumanidis M, O’regan M, Plouin P, Sander J, Scott R, Shorvon S, Treiman D, Wasterlain C, Wieshmann U.
Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports.
Epileptic Disord. 2005 7:253-96.
Liu RS, Lemieux L, Bell GS, Sisodiya SM, Bartlett PA, Shorvon SD, Sander JW, Duncan JS.
Cerebral Damage in Epilepsy: A Population-based Longitudinal Quantitative MRI Study.
Epilepsia. 2005 46:1482-94.
Shorvon S, Walker M.
Status epilepticus in idiopathic generalized epilepsy.
Epilepsia. 2005; 46 Suppl 9:73-9
Shorvon S.
An episode in the history of temporal lobe epilepsy: the quadrennial meeting of the ILAE in 1953.
Epilepsia. 2006;47:1288-91.
Tiamkao S, Shorvon SD.
Seizure-related injury in an adult tertiary epilepsy clinic.
Hong Kong Med J. 2006;12:260-3.
Shorvon S.
We live in the age of the clinical guideline.
Epilepsia. 2006 Jul;47(7):1091-3. No abstract available. Erratum in: Epilepsia 2006 47:1980.
Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M.
EFNS guideline on the management of status epilepticus.
Eur J Neurol. 2006;13:445-50.
Shorvon S.
The early history (1909-1961) of Epilepsia, the journal of the International League Against Epilepsy, and its echoes today.
Epilepsia. 2007;48:1-14.
Shorvon S, Luciano AL.
Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects.
Curr Opin Neurol. 2007 20:208-12.
Shorvon S.
The treatment of chronic epilepsy: a review of recent studies of clinical efficacy and side effects.
Curr Opin Neurol. 2007 20:159-63.
Luciano AL, Shorvon SD.
Results of treatment changes in patients with apparently drug-resistant chronic epilepsy.
Ann Neurol. 2007 Jan 25; [epub ahead of print]
Shorvon S
The prosecution of research–experience from Singapore.
Lancet. 2007:1835-7.
Sisodiya S, Cross JH, Blumcke I, Chadwick D, Craig J, Crino PB, Debenham P, Delanty N, Elmslie F, Gardiner M, Golden J, Goldstein D, Greenberg DA, Guerrini R, Hanna M, Harris J, Harrison P, Johnson MR, Kirov G, Kullman DM, Makoff A, Marini C, Nabbout R, Nashef L, Noebels JL, Ottman R, Pirmohamed M, Pitkanen A, Scheffer I, Shorvon S, Sills G, Wood N, Zuberi S.
Genetics of epilepsy : Epilepsy Research Foundation workshop report.
Epileptic Disord. 2007 9:194-236.
Shorvon SD, Trinka E, Walker MC The proceedings of the First London
Colloquium on Status Epilepticus — University College London, April 12-15, 2007.
Epilepsia 2007; 48 (S8) 1-3
Shorvon SD
What is nonconvulsive status epilepticus, and what are its subtypes?
Epilepsia 2007: 48 (S8): 35-38
Shorvon SD Fashion and cult in neuroscience — the case of hysteria
Brain 2007 130 (12) : 3342-3348
Schwartzkroin PA, Shorvon SD.
An update on Epilepsia.
Epilepsia. 2007 Nov;48(11):2007-9.
Shorvon S
What is nonconvulsive status epilepticus and what are its subtypes
Epilepsia 2007 48(Suppl 8) : 35-38
Shorvon S, Berg A.
Pertussis vaccination and epilepsy-an erratic history, new research and the
mismatch between science and social policy.
Epilepsia. 2008 49: 219-225
Gambardella A, Andermann F, Shorvon S, Le Piane E, Aguglia U.
Limited chronic focal encephalitis: another variant of Rasmussen syndrome?
Neurology. 2008 70: 374-7.
Neligan A, Shorvon SD.
Which should be the first-line drug for newly diagnosed epilepsy? Commentary on the SANAD study.
Pol Arch Med Wewn. 2008 118:11-3
Borelli P, Shorvon SD, Stevens JM, Smith SJ, Scott CA, Walker MC.
Extratemporal ictal clinical features in hippocampal sclerosis: their relationship to the degree of hippocampal volume loss and to the outcome of temporal lobectomy.
Epilepsia. 2008 49:1333-9.
Shorvon S, Baulac M, Cross H, Trinka E, Walker M; TaskForce on Status
Epilepticus of the ILAE Commission for European Affairs. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus.
Epilepsia. 2008 49:1277-85
Schwartzkroin PA, Shorvon SD.
Public (open) access policy.
Epilepsia. 2008 49:1295
Lo C, Shorvon SD, Luxon LM, Bamiou DD.
Saccadic eye movements and anti-epileptic drugs.
Epilepsy Res. 2008 78:93-101.
Chungath M, Shorvon S.
The mortality and morbidity of febrile seizures.
Nature Clin Pract Neurol. 2008 4:610-21.
Schwartzkroin PA, Shorvon SD.
From the editors.
Epilepsia. 2008 Dec;49(12):1979.
Schwartzkroin PA, Shorvon SD.
Raising the bar for acceptance; new length restrictions on Epilepsia manuscripts.
Epilepsia. 2009 50:585.
Shorvon SD.
Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009.
Epilepsia. 2009 50 Suppl 3:93-130.
Shorvon SD.
Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958.
Epilepsia. 2009 50 Suppl 3:69-92.
Neligan A, Shorvon SD.
The history of status epilepticus and its treatment.
Epilepsia. 2009 50 Suppl 3:56-68.
Shorvon SD.
A history of neuroimaging in epilepsy 1909-2009.
Epilepsia. 2009 50 Suppl 3:39-49.
Shorvon SD, Weiss G, Goodkin HP.
Notes on the origins of Epilepsia and the International League Against Epilepsy.
Epilepsia. 2009 50:368-76.
Shorvon SD, Schwartzkroin PA.
Epilepsia–the centenary issue.
Epilepsia. 2009 50:335-6.
Shorvon SD, Tomson T, Cock HR.
The management of epilepsy during pregnancy-Progress is painfully slow.
Epilepsia. 2009 50:973-974.
Elliott B, Joyce E, Shorvon S. Delusions, illusions and hallucinations in epilepsy: 2. Complex phenomena and psychosis.
Epilepsy Res. 2009 May 11.
[Epub ahead of print: 19442490].
Elliott B, Joyce E, Shorvon S.
Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena.
Epilepsy Res. 2009 May 5.
[Epub ahead of print: 19423297].
Shorvon S, Neligan A.
Risk of epilepsy after head trauma.
Lancet. 2009 28; 373(9669):1060-1.
Shorvon S, Tan R.
Uncommon causes of status epilepticus.
Epilepsia. 2009 50 Suppl 12:61-3.
Trinka E, Shorvon S.
The proceedings of the innsbruck colloquium on status epilepticus.
Epilepsia. 2009 50 Suppl 12:1-2.
Neligan A, Shorvon SD.
Traumatic brain injury results in prolonged increase in risk of epilepsy in children.
J Pediatr. 2009 155:449.
Adjei P, Surges R, Scott CA, Kallis C, Shorvon S, Walker MC.
Do subclinical electrographic seizure patterns affect heart rate and its variability?
Epilepsy Res. 2009 87:281-5
Menon B, Shorvon SD.
Ischaemic stroke in adults and epilepsy.
Epilepsy Res 2009 87:1-11.
Tan RY, Neligan A, Shorvon SD.
The uncommon causes of status epilepticus: a systematic review.
Epilepsy Res. 2010; 91:111-22.
Neligan A, Shorvon SD.
Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review.
Arch Neurol. 2010; 67:931-40.
Shorvon S, Trinka E.
Nonconvulsive status epilepticus and the postictal state.
Epilepsy Behav. 2010; 19:172-5.
Shorvon S, Guerrini R.
Acute symptomatic seizures–should we retain the term?
Epilepsia. 2010; 51:722-3.
Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, Holtkamp M;
European Federation of Neurological Societies. EFNS guideline on the management of status epilepticus in adults.
Eur J Neurol. 2010; 17:348-55.
Neligan A, Shorvon SD.
Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: A review.
Epilepsy Res. 2010 epub Oct 12.
Neligan A, Bell GS, Shorvon SD, Sander JW.
Temporal trends in the mortality of people with epilepsy: A review.
Epilepsia. 2010; 51:2241-6.
Neligan A, Bell GS, Johnson AL, Goodridge DM, Shorvon SD, Sander JW.
The long-term risk of premature mortality in people with epilepsy.
Brain. 2011 134:388-95.
Shorvon SD.
The causes of epilepsy: Changing concepts of etiology of epilepsy over the past 150 years.
Epilepsia. 2011 Apr 11. doi: 10.1111/j.1528-1167.2011.03051.x.
Shorvon SD. The etiologic classification of epilepsy.
Epilepsia. 2011 Mar 30. doi: 10.1111/j.1528-1167.2011.03041.x.
Shorvon S.
The treatment of status epilepticus.
Curr Opin Neurol. 2011 24:165-70.
Shorvon SD.
The causes of epilepsy: changing concepts of etiology of epilepsy over the past 150 years.
Epilepsia. 2011; 52(6):1033-44
Beghi E, Shorvon S.
Antiepileptic drugs and the immune system.
Epilepsia. 2011; 52 Suppl 3:40-4.
Shorvon S, Ferlisi M.
The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol.
Brain. 2011; 134(Pt 10):2802-18
Johnson MR, Shorvon SD.
Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait.
Epilepsy Behav. 2011; 22(3):421-7
Schwartzkroin PA, Shorvon S. Morris-Coole
Epilepsia Prize – 2010.
Epilepsia. 2011; 52(8):1375
Cock HR; ESETT Group.
Established status epilepticus treatment trial (ESETT).
Epilepsia. 2011; 52 Suppl 8:50-2
Shorvon S.
Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation.
Epilepsia. 2011; 52 Suppl 8:53-6
Shorvon S, Trinka E.
Status epilepticus–making progress.
Epilepsia. 2011; 52 Suppl 8:1-2
Shorvon S, Tomson T.
Sudden unexpected death in epilepsy.
Lancet. 2011; 378(9808):2028-38
Neligan A, Bell GS, Sander JW, Shorvon SD.
How refractory is refractory epilepsy? Patterns of relapse and remission in people with refractory epilepsy.
Epilepsy Res. 2011; 96(3):225-30.
Schwartzkroin PA, Shorvon SD. Morris-Coole
Epilepsia Prize – 2011.
Epilepsia. 2012 May 11. doi: 10.1111/j.1528-1167.2012.03514.x.
Neligan A, Bell GS, Giavasi C, Johnson AL, Goodridge DM, Shorvon SD, Sander JW.
Long-term risk of developing epilepsy after febrile seizures: A prospective cohort study.
Neurology. 2012 78(15):1166-70
Lo C, Shorvon S, Davis M, Houlden H, Gibbons V, Wood N.
Genetic linkage analysis of a large family with photoparoxysmal response.
Epilepsy Res. 2012; 99(1-2):38-45
Shorvon S, Ferlisi M.
The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy.
Brain. 2012 May 9. [Epub ahead of print] PubMed PMID: 22577217.
Shorvon S. Guidelines for status epilepticus: are we there yet?
Neurocrit Care. 2012 17(1):1-2.
Shorvon S. Clinical trials in acute repetitive seizures and status epilepticus.
Epileptic Disord. 2012 14(2):138-47.
Neligan A, Bell GS, Elsayed M, Sander JW, Shorvon SD. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up.
J Neurol Neurosurg Psychiatry. 2012 83(8):810-3
Tucci A, Kara E, Schossig A, Wolf NI, Plagnol V, Fawcett K, Paisan-Ruiz C, Moore M, Hernandez D, Musumeci S, Tennison M, Hennekam R, Palmeri S, Malandrini A, Raskin S, Donnai D, Hennig C, Tzschach A, Hordijk R, Bast T, Wimmer K, Lo CN, Shorvon S, Mefford H, Eichler EE, Hall R, Hayes I, Hardy J, Singleton A, Zschocke J, Houlden H. Kohlschutter-Tonz
Syndrome: Mutations in ROGDI and Evidence of Genetic Heterogeneity.
Hum Mutat. 2012 Oct 19. doi: 10.1002/humu.22241.
Yasiry Z, Shorvon SD
How phenobarbital revolutionized epilepsy therapy: the story of phenobarbital therapy in epilepsy in the last 100 years.
Epilepsia. 2012 Dec;53 Suppl 8:26-39.
Shorvon S.
The historical evolution of, and the paradigms shifts in, the therapy of convulsive status epilepticus over the past 150 years.
Epilepsia. 2013 Sep;54 Suppl 6:64-7.
Shorvon S, Trinka E.
The London-Innsbruck Status Epilepticus Colloquia 2007-2011, and the main advances in the topic of status epilepticus over this period.
Epilepsia. 2013 Sep;54 Suppl 6:11-3
Trinka E, Shorvon S.
Status epilepticus–where are we in 2013?
Epilepsia. 2013 Sep;54 Suppl 6:1-2.
Zaccara G, Sisodiya SM, Giovannelli F, Walker MC, Heaney DC, Angus-Leppan H, Wehner T, Eriksson SH, Liu R, Rugg-Gunn F, Shorvon SD, Sander JW.
Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy.
Br J Clin Pharmacol. 2013 Nov;76(5):827-8.
Shorvon S, Schwartzkroin PA.
Epilepsia and the rough seas of medical publishing.
Epilepsia. 2013 Jun;54(6):955-8.
Steinhoff BJ, Ben-Menachem E, Ryvlin P, Shorvon S, Kramer L, Satlin A, Squillacote D, Yang H, Zhu J, Laurenza A.
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
Epilepsia. 2013 Aug;54(8):1481-9.
Gregoris N, Shorvon S.
What is the enduring value of research publications in clinical epilepsy? An assessment of papers published in 1981, 1991, and 2001.
Epilepsy Behav. 2013 Sep;28(3):522-9.
Shorvon SD.
New terminologies: the downsides.
Epilepsia. 2013 Jun;54(6):1134.
Shorvon SD, Goodridge DM.
Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies.
Brain. 2013 Nov;136(Pt 11):3497-510.
Goodridge DM, Shorvon SD.
The contribution of British general practice to our knowledge of epilepsy and its effects on people.
Br Med Bull. 2013;108:115-30.
Shorvon S.
The historical evolution of, and the paradigms shifts in, the therapy of convulsive status epilepticus over the past 150 years. Epilepsia. 2013 Sep;54 Suppl 6:64-7.
Shorvon S, Trinka E. The London-Innsbruck
2007-2011, and the main advances in the topic of status epilepticus over this period. Epilepsia. 2013 Sep;54 Suppl 6:11-3.
Alkhamees HA, Selai CE, Shorvon SD, Kanner AM
The use of the NDDI-E in Arabic to identify symptoms of depression of moderate or greater severity in people with epilepsy. Epilepsy Behav. 2014 32:55-8.
Yasiry Z, Shorvon SD.
The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure. 2014 23(3):167-174.
Shorvon S.
The evolution of epilepsy theory and practice at the National Hospital for the Relief and Cure of Epilepsy, Queen Square between 1860 and 1910. Epilepsy Behav. 2014 31:228-42.
Shorvon S.
The concept of symptomatic epilepsy and the complexities of assigning cause in epilepsy. Epilepsy Behav. 2014 32C:1-8.
Ferlisi M, Shorvon S.
Seizure precipitants (triggering factors) in patients with epilepsy. Epilepsy Behav. 2014 33:101-5.
Hocker SE, Shorvon S.
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014 83(9):866.
Shorvon S.
What epilepsy comorbidities are important to model in the laboratory? Clinical perspectives. Adv Exp Med Biol. 2014;813:265-71.
Malmgren K, Rydenhag B, Baxendale S, Thompson PJ, Duncan JS, Shorvon S, Helmstaedter C, Elger CE.
Concerns about bilateral radiosurgical treatment of a patient with bilateral temporal lobe epilepsy. Epilepsia. 2014 55(4):623.
Shorvon S, Trinka E.
The 5th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. Epilepsy Behav. 2015 49:1-3.
Bhatnagar M, Shorvon S.
Genetic mutations associated with status epilepticus. Epilepsy Behav. 2015 49:104-10.
Ferlisi M, Hocker S, Grade M, Trinka E, Shorvon S
International Steering Committee of the Step Audit. Preliminary results of the global audit of treatment of refractory status epilepticus. Epilepsy Behav. 2015 ;49:318-24.
Alkhamees HA, Selai CE, Shorvon SD.
The beliefs among patients with epilepsy in Saudi Arabia about the causes and treatment of epilepsy and other aspects. Epilepsy Behav. 2015 53:135-9.
Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH.
A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015 56(10):1515-23.
Shorvon S, Trinka E. The 5th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. Epilepsy Behav. 2015 Aug;49:1-3.
Bell GS, Neligan A, Giavasi C, Keezer MR, Novy J, Peacock JL, Johnson AL,
Goodridge DM, Shorvon SD, Sander JW. Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study.
J Neurol Neurosurg Psychiatry. 2016 Jan 18. pii
Trinka E, Brigo F, Shorvon S. Recent advances in status epilepticus.
Curr Opin Neurol. 2016 Apr;29(2):189-98.
Shorvon S, Schmidt D. The right and the wrong with epilepsy and her science.
Epilepsia Open. 2016 Aug 31;1(3-4):76-85.
Shorvon SD, Trinka E, Steinhoff BJ, Holtkamp M, Villanueva V, Peltola J,
Ben-Menachem E. Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
J Neurol. 2017 Mar;264(3):421-431.
Shorvon SD, Bermejo PE, Gibbs AA, Huberfeld G, Kälviäinen R. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection. Epilepsy Behav. 2018 Mar 27;82:91-103.
Shorvon S. How the coming of the NHS changed British neurology. Brain. 2018 Apr 6. doi: 10.1093/brain/awy090. [Epub ahead of print] PubMed PMID: 29659733).
Shorvon SD, Bermejo PE, Gibbs AA, Huberfeld G, Kälviäinen R. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection. Epilepsy Behav. 2018 May;82:91-103.
Shorvon S. How the coming of the NHS changed British neurology. Brain. 2018 May 1;141(5):1570-1575.
Shorvon S, Luxon L. The Royal College of Physicians at 500 years: changing roles and challenges. Lancet. 2018 Sep 22;392(10152):1004-1007.
Ferlisi M, Hocker S, Trinka E, Shorvon S; International Steering Committee of the StEp Audit. Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit. Epilepsia. 2018 Oct; 59 Suppl 2:100-107.
Trinka E, Shorvon S. A decade of progress in status epilepticus 2007-2017: Proceedings of the 6th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. Epilepsia. 2018 Oct; 59 Suppl 2:67-69.
Shorvon S. Paediatric status epilepticus-A series of timely reviews. Seizure. 2018 Oct 12. pii: S1059-1311(18)30653-8.
Shorvon S, Trinka E. Regulatory aspects of status epilepticus. Epilepsia. 2018;59
Suppl 2:128-134.
Shorvon S. Psychoanalytical concepts of epilepsy. Epilepsy Behav. 2019;
101(Pt A):106599.
Shorvon S, Trinka E, Walker M. The seventh London-Innsbruck Colloquium on
Status Epilepticus and Acute Seizures. Epilepsy Behav. 2019;101(Pt B):106532.
Ferlisi M, Hocker S, Trinka E, Shorvon S; International Steering Committee of
the StEp Audit. The anesthetic drug treatment of refractory and super-refractory
status epilepticus around the world: Results from a global audit. Epilepsy Behav.
2019; 101(Pt B):106449.
Shorvon SD. The first 100 years of the ILAE (1909-2009): Its landmarks,
achievements, and challenges. Epilepsia Open. 2019 20;4(2):237-246.
Neligan A, Noce AJ, Gosavi TD, Shorvon SD, Kohler S. Walker MC; Change in mortality of generalized convulsive status epilepticus in high income countries over time: a systematic review and meta-analysis.
JAMA Neurology 2019; 76: 897-905
Shorvon S. Psychoanalytical concepts of epilepsy. Epilepsy Behav. 2019 Dec;101(Pt A):106599.
Shorvon S, Trinka E, Walker M. The seventh London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. Epilepsy Behav. 2019;101(Pt B):106532.
Shorvon S, Sen A. What is status epilepticus and what do we know about its
epidemiology? Seizure. 2020; 75:131-136.
Shorvon SD. The enigmatic figure of Leon Pierce Clark and his contribution to epilepsy. Epilepsia Open. 2022 Mar 5. doi: 10.1002/epi4.12589.
Shorvon S. Dropping the pilot and the ending of an era: The retirement of Dr. Steven Schachter from the editorship of Epilepsy & Behavior. Epilepsy Behav. 2022 Dec;137(Pt B):108774.
Gaspard N, Shorvon S. Is NORSE a meaningful clinical entity? Epilepsy Behav. 2023 Apr;141:109097.